Article
Biochemistry & Molecular Biology
Dieter Petit, Manuel Hitzenberger, Matthias Koch, Sam Lismont, Katarzyna Marta Zoltowska, Thomas Enzlein, Carsten Hopf, Martin Zacharias, Lucia Chavez-Gutierrez
Summary: This study investigates the interactions between an imidazole-based GSM and its target gamma-secretase-APP, and reveals that a part of the modulator interacts with a binding site on gamma-secretase, triggering rearrangements and stabilizing enzyme-substrate interactions.
Article
Biochemistry & Molecular Biology
Matthias Koch, Thomas Enzlein, Shu-Yu Chen, Dieter Petit, Sam Lismont, Martin Zacharias, Carsten Hopf, Lucia Chavez-Gutierrez
Summary: This study explores the mechanism that controls the processing of the amyloid precursor protein (APP) by gamma-secretases, which is crucial in determining the length of amyloid-beta (A beta) peptides and their role in Alzheimer's disease (AD) pathogenesis. The researchers found that polar interactions established by the APPC99 ectodomain (ECD) play a key role in regulating the cleavage of APP by gamma-secretases. Increasing the hydrophobicity of APPC99-ECD attenuates substrate-driven product release and rescues the effects of Alzheimer's disease-associated pathogenic gamma-secretase and APP variants on A beta length. Furthermore, the study reveals that APPC99-ECD facilitates the production of longer A beta peptides caused by certain gamma-secretase inhibitors. These findings highlight the importance of the APPC99-ECD in regulating gamma-secretase activity and suggest it as a potential target for developing compounds that can selectively promote APP processing by these enzymes.
Article
Biochemistry & Molecular Biology
Shiveena Bhatia, Manjinder Singh, Pratibha Sharma, Somdutt Mujwar, Varinder Singh, Krishna Kumar Mishra, Thakur Gurjeet Singh, Tanveer Singh, Sheikh Fayaz Ahmad
Summary: Alzheimer's disease, the leading cause of dementia, is characterized by the deposition of plaques and tangles in the brain, leading to cell degeneration. Researchers are developing BACE-1 enzyme inhibitors to prevent plaque buildup. In this study, Elenbecestat analogues were analyzed using structure-based drug design and scaffold morphing, and SB306 and SB12 were found to interact well with the catalytic dyad motifs of the enzyme, showing drug-like properties and high thermodynamic stability.
Review
Pharmacology & Pharmacy
Bruno P. Imbimbo, Stefania Ippati, Mark Watling, Camillo Imbimbo
Summary: According to the beta-amyloid (A beta) hypothesis, brain A beta accumulation is the primary cause of cognitive deficit and dementia in Alzheimer's disease (AD). While many anti-A beta drugs have failed in clinical trials, recent studies have shown encouraging results for antibodies that clear amyloid plaques. These findings suggest that decreased levels of soluble monomeric A beta may be the main driver of AD, rather than the aggregated forms.
PHARMACOLOGICAL RESEARCH
(2023)
Article
Plant Sciences
Julio Rea Martinez, Gordana Selo, Maria Angeles Fernandez-Arche, Beatriz Bermudez, Maria Dolores Garcia-Gimenez
Summary: Compounds from hempseed have shown beneficial effects on neuro-inflammation and can inhibit the expression of genes involved in the accumulation of Aβ plaques. These compounds also positively affect transcription factors related to complex biological functions.
JOURNAL OF NATURAL PRODUCTS
(2021)
Article
Clinical Neurology
Yaqi Wang, Yuting Cui, Jing Liu, Qiao Song, Min Cao, Yuli Hou, Xiaomin Zhang, Peichang Wang
Summary: The upregulation of KLF5 is found to positively regulate BACE1 and accelerate APP amyloidogenic cleavage in Alzheimer's disease (AD) progression. The levels of KLF5 significantly increase in AD patients and APP/PS1 mice, and are closely related to cognitive capacity. KLF5 promotes amyloidogenic metabolism and AP synthesis through BACE1.
ALZHEIMERS RESEARCH & THERAPY
(2022)
Article
Neurosciences
Jonathan Aow, Tzu-Rung Huang, Gopal Thinakaran, Edward H. Koo
Summary: In this study, the researchers found that there was a significant early and aberrant Bace1-mediated APP cleavage in the presence of APP/Bace1 co-expression. This led to disturbances in the trafficking of full-length APP (fl-APP) from the secretory pathway, resulting in a substantial loss of surface fl-APP and a marked reduction in APP internalization. Therefore, caution is needed when interpreting results where APP is detected only with a C-terminal tag in the presence of Bace1 co-expression, and previous findings may need to be reinterpreted if it is unclear whether fl-APP is present in normal physiological levels.
MOLECULAR NEUROBIOLOGY
(2022)
Review
Geriatrics & Gerontology
Jiaxuan Li, Xin Wu, Xin Tan, Shixin Wang, Ruisi Qu, Xiaofeng Wu, Zhouqing Chen, Zhong Wang, Gang Chen
Summary: This meta-analysis found that anti-A beta drugs do not have an effect on cognitive performance in AD patients, but monoclonal antibodies can delay cognitive decline. Development of other types of anti-A beta drugs should proceed with caution.
FRONTIERS IN AGING NEUROSCIENCE
(2023)
Review
Neurosciences
Gunnar Nordvall, Johan Lundkvist, Johan Sandin
Summary: Recent clinical data have shown that removing A beta-amyloid plaques in early Alzheimer's disease can slow down disease progression. This progress validates the amyloid cascade hypothesis and highlights the importance of targeting A beta-amyloid for therapeutic purposes. It also suggests that reducing the production of amyloidogenic A beta can prevent the formation of A beta-pathology. Further research is needed to explore the potential of gamma-secretase modulators in preventing and treating Alzheimer's disease.
FRONTIERS IN MOLECULAR NEUROSCIENCE
(2023)
Article
Neurosciences
Z. J. Franklin, L. Croce, R. Dekeryte, M. Delibegovic, B. Platt
Summary: Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two prevalent age-related diseases that share common pathologies. A study found that neuronal hBACE1 knock-in not only leads to an AD-like phenotype but also a T2DM-like phenotype. This study aims to analyze the age-related changes in AD and T2DM-like pathologies in the PLB4 mouse.
NEUROBIOLOGY OF DISEASE
(2023)
Article
Biochemistry & Molecular Biology
Meewhi Kim, Ilya Bezprozvanny
Summary: Proteolytic processing of amyloid precursor protein (APP) is critical in the pathogenesis of Alzheimer's disease (AD). Mutations in APP, PS1, or PS2 affect APP proteolysis by gamma-secretase and influence the levels of A beta 40 and A beta 42 peptides. This paper proposes a mechanistic hypothesis that may reconcile conflicting ideas and observations regarding the role of A beta peptides and gamma-secretase in AD.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Chemistry, Medicinal
Weimin Qiu, Hui Liu, Yijun Liu, Xin Lu, Lei Wang, Yanyu Hu, Feng Feng, Qi Li, Haopeng Sun
Summary: Alzheimer's disease (AD) is a difficult to treat progressive neurodegenerative disease characterized by the accumulation of amyloid beta (A beta) plaques in the brain. A beta interacts with various receptors on the plasma membrane and mediates signaling pathways that contribute to the development of AD. Despite ongoing research, there are currently no effective medications for AD. This review discusses the importance of A beta in the pathogenesis of AD, recent progress in targeting A beta-related receptors and compounds, and the challenges and opportunities in developing effective therapies for AD.
MEDICINAL RESEARCH REVIEWS
(2023)
Article
Neurosciences
Ye-Ran Wang, Meng-Ting Wang, Xiao-Qin Zeng, Yu-Hui Liu, Yan-Jiang Wang
Summary: This study found lower plasma levels of NAbs-PS1 in AD patients, which were negatively associated with brain A beta load and positively associated with cognitive functions. Plasma NAbs-PS1 could be potential biomarkers for distinguishing AD patients from non-AD cognitive impairment subjects.
JOURNAL OF ALZHEIMERS DISEASE
(2022)
Article
Biochemistry & Molecular Biology
Meewhi Kim, Ilya Bezprozvanny
Summary: Proteolytic processing of amyloid precursor protein (APP) is critical in the pathogenesis of Alzheimer's disease (AD), with mutations causing increased Aβ42 production. Different conformations of gamma secretase with APP affect the amyloidogenic processing of APP. Analyzing protein structure can provide insights into the preferred processing of APP in different subcellular locations.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Neurosciences
Can Zhang, Shivangi M. Inamdar, Swathi Swaminathan, Daniel R. Marenda, Aleister J. Saunders
Summary: This study identifies a loss-of-function mechanism of Ubiquilin-1 in Alzheimer's disease and highlights the significance of targeting Ubiquilin-1-mediated protein quality control as a potential therapeutic strategy.
FRONTIERS IN NEUROSCIENCE
(2022)
Article
Gastroenterology & Hepatology
Julia Yuen Hang Liu, Peng Du, John Anthony Rudd
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
(2020)
Review
Multidisciplinary Sciences
Peng Du, Julia Y. H. Liu, Atchariya Sukasem, Anna Qian, Stefan Calder, John A. Rudd
JOURNAL OF THE ROYAL SOCIETY OF NEW ZEALAND
(2020)
Article
Food Science & Technology
Julia Y. H. Liu, Michelle Y. Y. Sun, Nerina Sommerville, Man Piu Ngan, Eugene D. Ponomarev, Ge Lin, John A. Rudd
FOOD AND CHEMICAL TOXICOLOGY
(2020)
Article
Neurosciences
Yayi Sun, Nerina R. Sommerville, Julia Yuen Hang Liu, Man Piu Ngan, Daniel Poon, Eugene D. Ponomarev, Zengbing Lu, Jeng S. C. Kung, John A. Rudd
JOURNAL OF PHYSIOLOGY-LONDON
(2020)
Article
Clinical Neurology
Nashwa Amin, Shiyi Xie, Xiaoning Tan, Yili Chen, Qiannan Ren, Benson O. A. Botchway, Shaohua Hu, Yongchun Ma, Zhiying Hu, Marong Fang
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
(2020)
Review
Gastroenterology & Hepatology
Paul L. R. Andrews, Weigang Cai, John A. Rudd, Gareth J. Sanger
Summary: Nausea as an early symptom of COVID-19 deserves more attention, and mediators released from infected intestinal epithelial cells may play a role in inducing vomiting.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
(2021)
Article
Physiology
Zengbing Lu, Yu Zhou, Longlong Tu, Sze Wa Chan, Man P. Ngan, Dexuan Cui, Yuen Hang Julia Liu, Ianto Bosheng Huang, Jeng S. C. Kung, Chung Man Jessica Hui, John A. Rudd
Summary: This study aimed to investigate the application of advanced analytical techniques in analyzing disrupted gastric myoelectric activity (GMA) recorded after the administration of sulprostone, a prostaglandin E-3/1 agonist, in ferrets, to better understand its effects on gastric function.
FRONTIERS IN PHYSIOLOGY
(2021)
Article
Cell Biology
Julia Y. H. Liu, Peng Du, Zengbing Lu, Jeng S. C. Kung, Ianto B. Huang, Jessica C. M. Hui, Heidi S. H. Ng, M. P. Ngan, Dexuan Cui, Bin Jiang, S. W. Chan, John A. Rudd
Summary: The study indicates that TRPV1 and TRPA1 play a minor role in regulating pacemaker potentials, and non-specific actions at other TRP and ion channels likely contribute to the overall effects on the electrophysiological recordings observed.
Article
Pharmacology & Pharmacy
Longlong Tu, Julia Y. H. Liu, Zengbing Lu, Dexuan Cui, Man P. Ngan, Peng Du, John A. Rudd
Summary: The study showed that cisplatin treatment disrupted ICC networking and viability in Suncus murinus, and also affected general homeostatic mechanisms of the cardiovascular system and gastrointestinal tract. The effect on the gastrointestinal tract appeared to be region-specific. Further investigations are required to comprehensively understand these mechanistic effects of cisplatin and their relationship to emesis.
FRONTIERS IN PHARMACOLOGY
(2021)
Meeting Abstract
Biochemistry & Molecular Biology
Chung Man, Jessica Hui, Peng Du, Yuen Hang Julia Liu, Zengbing Lu, Dexuan Cui, Bing Jiang, Man Piu Ngan, Shuk Han Ng, Lingqing Yang, Aleena Khalid, Luping Liu, John A. Rudd
Article
Pharmacology & Pharmacy
Zengbing Lu, Dexuan Cui, Julia Yuen Hang Liu, Bin Jiang, Man Piu Ngan, Ichiro Sakata, Shota Takemi, Takafumi Sakai, Ge Lin, Sze Wa Chan, John A. Rudd
Summary: NESFATIN-1, encoded by NUCB2, is a potent regulator of feeding and emesis in Suncus murinus, with its expression level in the brain and gastrointestinal tract being influenced by fasting. It can induce emesis, suppress food intake and water intake, but has no significant effect on locomotor activity.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Pharmacology & Pharmacy
Halina Was, Agata Borkowska, Ana Bagues, Longlong Tu, Julia Y. H. Liu, Zengbing Lu, John A. Rudd, Kulmira Nurgali, Raquel Abalo
Summary: Chemotherapeutic drugs are extensively used in cancer treatment, but their severe side effects on the nervous system can reduce the efficacy of treatment and patients' quality of life. This review discusses the main effects of chemotherapy on the peripheral and central nervous systems, including neuropathic pain, chemobrain, enteric neuropathy, as well as nausea and emesis.
FRONTIERS IN PHARMACOLOGY
(2022)
Editorial Material
Pharmacology & Pharmacy
Kulmira Nurgali, John A. Rudd, Halina Was, Raquel Abalo
FRONTIERS IN PHARMACOLOGY
(2022)
Meeting Abstract
Gastroenterology & Hepatology
Chung Man Jessica Hui, Peng Du, Yuen Hang Julia Liu, Zengbing Lu, Man Piu Ngan, Dexuan Cui, Bin Jiang, Shuk Hang Ng, Lingqing Yang, Aleena Khalid, Luping Liu, John A. Rudd
Proceedings Paper
Engineering, Biomedical
Julia Y. H. Liu, John A. Rudd, Peng Du
Summary: This study utilized a micro-electrode array to record intestinal slow waves and developed a pipeline for signal extraction and metric analysis, identifying various major propagation patterns.
2021 43RD ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE & BIOLOGY SOCIETY (EMBC)
(2021)